ALX Oncology Holdings, Inc. (ALXO)
2.025
+0.04
(+1.76%)
USD |
NASDAQ |
Aug 25, 12:31
ALX Oncology Holdings Max Drawdown (5Y) : 99.64% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.64% |
| June 30, 2026 | 99.64% |
| May 31, 2026 | 99.64% |
| April 30, 2026 | 99.64% |
| March 31, 2026 | 99.64% |
| February 28, 2026 | 99.64% |
| January 31, 2026 | 99.64% |
| December 31, 2025 | 99.64% |
| November 30, 2025 | 99.64% |
| October 31, 2025 | 99.64% |
| September 30, 2025 | 99.64% |
| August 31, 2025 | 99.64% |
| July 31, 2025 | 99.64% |
| June 30, 2025 | 99.64% |
| May 31, 2025 | 99.64% |
| April 30, 2025 | 99.57% |
| March 31, 2025 | 99.44% |
| February 28, 2025 | 99.07% |
| January 31, 2025 | 98.92% |
| December 31, 2024 | 98.92% |
| November 30, 2024 | 98.92% |
| October 31, 2024 | 98.77% |
| September 30, 2024 | 98.39% |
| August 31, 2024 | 97.95% |
| July 31, 2024 | 96.27% |
| Date | Value |
|---|---|
| June 30, 2024 | 96.27% |
| May 31, 2024 | 96.27% |
| April 30, 2024 | 96.27% |
| March 31, 2024 | 96.27% |
| February 29, 2024 | 96.27% |
| January 31, 2024 | 96.27% |
| December 31, 2023 | 96.27% |
| November 30, 2023 | 96.27% |
| October 31, 2023 | 96.27% |
| September 30, 2023 | 96.27% |
| August 31, 2023 | 96.27% |
| July 31, 2023 | 96.11% |
| June 30, 2023 | 96.11% |
| May 31, 2023 | 96.11% |
| April 30, 2023 | 96.11% |
| March 31, 2023 | 95.97% |
| February 28, 2023 | 94.75% |
| January 31, 2023 | 94.75% |
| December 31, 2022 | 94.75% |
| November 30, 2022 | 94.75% |
| October 31, 2022 | 94.75% |
| September 30, 2022 | 94.75% |
| August 31, 2022 | 94.75% |
| July 31, 2022 | 94.75% |
| June 30, 2022 | 94.75% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Anixa Biosciences, Inc. | 70.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -56.95 |
| Beta (5Y) | 0.4218 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 112.7% |
| Historical Sharpe Ratio (5Y) | -0.471 |
| Historical Sortino (5Y) | -1.099 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.39% |